--- title: Undruggable description: Sign up now to hear this special 5-part podcast series. image: https://viewonline.the-scientist.com/hubfs/Undruggable_Logo_10-5.png --- ![40323-TS-Amgen-LabTalk-2p](https://viewonline.the-scientist.com/hs-fs/hubfs/40323-TS-Amgen-LabTalk-2p.png?width=990&name=40323-TS-Amgen-LabTalk-2p.png "40323-TS-Amgen-LabTalk-2p") # Undruggable - A special 5-part podcast series Welcome to Undruggable, a special edition podcast series produced by *The Scientist’s* Creative Services Team. This series is brought to you by Amgen, a pioneer in the science of using living cells to make biologic medicines. They helped invent the processes and tools that built the global biotech industry, and have since reached millions of patients suffering from serious illnesses around the world with their medicines. Beginning with the introduction of aspirin at the start of the 20th century, there have been three major waves of innovation in drug discovery. While breakthrough discoveries have been made, 85% of disease targets are still considered undruggable, which represents an ongoing barrier to discovering medicines for complex diseases like cancer and autoimmune conditions. Ray Deshaies, who has spent decades in academic research and is a senior vice president at Amgen, believes that the fourth wave of innovation is here, led by new types of multispecific medicines that will radically alter our concept of how drugs can work and pave the way for new solutions. **Sign up now to receive an email when each podcast episode airs.** - Episode 1 - The Next Wave of Drug Development ***October 21, 2021*** - Episode 2 - Drugging the Undruggable: The Biology of PROTACs ***October 28, 2021*** - Episode 3 - Discovery at the DNA Encoded Library ***November 4, 2021*** - Episode 4 - The Emerging Induced Proximity Toolkit ***November 11, 2021*** - Episode 5 - Induced Proximity for Cancer and Beyond ***November 18, 2021*** **[Visit this page to sign up for the Undruggable Q&A series, airing soon!](https://webinars.the-scientist.com/undruggable-qa-signup)** - Webinar 1 - The Next Wave of Drug Development and Drugging the Undruggable: The Biology of PROTACs ***November 3, 2021*** - Webinar 2 - Discovery at the DNA Encoded Library ***November 10, 2021*** - Webinar 3 - The Emerging Induced Proximity Toolkit ***November 17, 2021***     Host ![Deshaies](https://viewonline.the-scientist.com/hubfs/1516238263875.jpg "Deshaies") Ray Deshaies, PhD Senior Vice President Global Research Amgen **Sponsor** ![Amgen.png](https://viewonline.the-scientist.com/hs-fs/hubfs/1.1-%20All-Images/Allan%20Utton/Amgen_Tombstone.jpg?width=200&name=Amgen_Tombstone.jpg "Amgen.png") # Sign up and listen now ### TS\_Podcast\_Amgen\_Series 2\_Undruggable\_#403179 Information you provide will be held in confidence and will be shared with the sponsoring vendor(s) of this podcast. We may use the information to contact you about your account and to let you know about related programs and products; you may opt-out at any time. This allows *The Scientist* to keep these podcasts free of charge for our readers. The Scientist c/o LabX Media Group 1000 N West Street, Suite 1200, Wilmington, Delaware, United States, 19801 Toll Free: 888.788.0328 | Phone: 705.528.6888 Email: [privacy@the-scientist.com](mailto:privacy@the-scientist.com) [Privacy Policy](https://www.the-scientist.com/privacy-policy) © 1986-2022 [The Scientist](http://the-scientist.com/)   [![The Scientist Logo\_white](https://viewonline.the-scientist.com/hs-fs/hubfs/The%20Scientist%20Logo_white.png?width=702&name=The%20Scientist%20Logo_white.png "The Scientist Logo_white")](https://www.the-scientist.com) The Scientist needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our [Privacy Policy.](https://www.the-scientist.com/privacy-policy)